The Neuroscience Research Priority Area (NRPA) supports a "collaborative matrix," bringing together diverse groups of investigators, trainees, and research groups from across the University. The impressive depth of neuroscience expertise at UK combined with an engaged community has led to a dynamic and exciting research environment. In support of its mission to develop initiatives that reinforce and promote that success, the NRPA’s guiding strategy is to provide broad-based support to neuroscience researchers across the university.
Join the NRPA!
We welcome new/experienced research collaborators to join the Neuroscience RPA team.
The Latest in Neuroscience at UK
New award advances Sanders-Brown director’s research on inflammation’s role in Alzheimer’s
The University of Kentucky Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., hopes to shed light on how specific brain cells may contribute to the progression of Alzheimer’s disease, paving the way for potential new therapeutic approaches.
Van Eldik recently received a three-year, $300,000 award from the BrightFocus Foundation to support her research project, “Relationship between astrocyte p38 MAPK, neuroinflammation, and Alzheimer pathology.”
UK researchers find Alzheimer’s-like brain changes in long COVID patients
New research from the University of Kentucky’s Sanders-Brown Center on Aging shows compelling evidence that the cognitive impairments observed in long COVID patients share striking similarities with those seen in Alzheimer’s disease and related dementias.
NIH funds UK’s groundbreaking DBS-Plus trial for Parkinson’s
This groundbreaking clinical study by neurosurgeon Dr. Craig van Horne and his UK team aims to reverse the effects of Parkinson's. Since the 1800s, scientists have known that peripheral nerves, which exist outside the brain and spinal cord, possess regenerative qualities that central nervous system nerves do not. The UK team hopes to leverage those regenerative effects within the brain, potentially halting or reversing nerve damage caused by Parkinson’s.
